Our Application

Worldwide 600+ million people live with diabetes*, yet blood glucose monitoring today is highly invasive, expensive and stigmatizing.

Less than half of those people have been diagnosed, and the number using blood glucose monitoring technology is even smaller.

Glucose measurement is the most important metric in diabetes management. The challenges of current blood glucose monitoring solutions can lead to poor adoption** and management** with the potential to result in depression, blindness and amputations.

*IDF Atlas 2021, **WHO ISBN 92 4 159493 4

Type 2 diabetes will be the initial application of our pioneering breath analysis technology.

At BOYDSense, we have the opportunity to revolutionize glucose monitoring. Our technology will provide a simple, accurate, pain-free and cost-effective solution accessible to people around the world.

Analysis of an individual’s exhaled metabolites such as VOCs will allow active monitoring of glucose levels, whether determining pre-diabetes at a healthcare review or evaluating the glucose level of a type 2 diabetic, on the go.

Text highlighting large statistic of diabetes patients in blue circle

Our experience and expertise in MedTech and diabetes means that we understand the challenges of the category and the opportunities to deliver dramatic improvements to patients’ lives around the world.

Our ongoing device development, and latest clinical investigations continue to move our technology and devices toward market launch. Our validated clinical studies and congress contributions demonstrate the accuracy, reliability, and patient acceptance of our technology in breath glucose monitoring for diabetes.

While our first application will be in type 2 diabetes, our developing technology, devices and platforms have potential for many applications, offering a rich sampling matrix for monitoring and assessment across a range of health conditions and diseases.

Key Benefits

Icon showing lightning strike representing pain with a line through it

Pain-free solution

Established blood glucose monitoring methods are painful, invasive and complex to use. Breath glucose monitoring offers a pain-free solution, through the analysis of exhaled breath.

Icon showing 3 numbered steps in circles connected by a white line

Simple & easy to use

Fully non-invasive and rated easy to use by over 95% of patients trialled.*** Breath glucose monitoring offers simple, intuitive sampling with reduced steps compared to traditional blood glucose monitoring.

***BOYDSense SAS, data on file

Icon showing a dollar sign and a downwards pointing arrow

Cost-effective

Requiring minimal consumables, this cost-effective solution increases accessibility to insurance providers and patients, with lower cost per patient per year over 3 years compared to blood glucose monitoring.

Icon showing a target with a check mark in the centre

Accurate & efficient

Accurate, efficient sampling and analysis for risk stratification, detection and monitoring. Early trials demonstrate 99.3% reliable measurements after single test.****

****BOYDSense SAS, data on file

Icon showing a trash can with a line through it

Less consumables

Simplified sampling with reduced consumables compared to blood glucose monitoring, lowering prescription requirements and costs.

Icon showing an arrow twisting in a figure of 8 with a line through it

Less hassle

Subtle, streamlined sampling procedures and on-board analysis allow active monitoring of breath glucose levels on the go. Increasing early engagement and compliance.

Created by a strong leadership team, each with over 25 years experience